Fintel reports that on April 19, 2023, Morgan Stanley maintained coverage of Align Technology (NASDAQ:ALGN) with a Overweight recommendation.
Analyst Price Forecast Suggests 1.36% Downside
As of April 6, 2023, the average one-year price target for Align Technology is $343.33. The forecasts range from a low of $191.90 to a high of $441.00. The average price target represents a decrease of 1.36% from its latest reported closing price of $348.05.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Align Technology is $3,890MM, an increase of 4.16%. The projected annual non-GAAP EPS is $8.05.
What are Other Shareholders Doing?
UOPIX - Ultranasdaq-100 Profund Investor Class holds 2K shares representing 0.00% ownership of the company. In it's prior filing, the firm reported owning 3K shares, representing a decrease of 18.78%. The firm decreased its portfolio allocation in ALGN by 2.35% over the last quarter.
MRGAX - MFS Core Equity Fund A holds 21K shares representing 0.03% ownership of the company. In it's prior filing, the firm reported owning 21K shares, representing an increase of 1.25%. The firm decreased its portfolio allocation in ALGN by 20.97% over the last quarter.
Camber Capital Management holds 375K shares representing 0.49% ownership of the company. In it's prior filing, the firm reported owning 200K shares, representing an increase of 46.67%. The firm increased its portfolio allocation in ALGN by 113.86% over the last quarter.
AMF Pensionsforsakring AB holds 24K shares representing 0.03% ownership of the company. No change in the last quarter.
Tekla Healthcare Opportunities Fund holds 25K shares representing 0.03% ownership of the company. In it's prior filing, the firm reported owning 12K shares, representing an increase of 53.41%. The firm increased its portfolio allocation in ALGN by 98.98% over the last quarter.
What is the Fund Sentiment?
There are 1563 funds or institutions reporting positions in Align Technology.
This is a decrease
of
13
owner(s) or 0.82% in the last quarter.
Average portfolio weight of all funds dedicated to ALGN is 0.23%,
an increase
of 14.80%.
Total shares owned by institutions decreased
in the last three months by 0.55% to 79,020K shares.
The put/call ratio of ALGN is 0.83, indicating a
bullish
outlook.
Align Technology Background Information
(This description is provided by the company.)
Align Technology designs, manufactures and offers the Invisalign® system, the most advanced clear aligner system in the world, iTero® intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 200 thousand doctor customers, and is key to accessing Align's 500 million consumer market opportunity worldwide. Align has helped doctors treat over 9.6 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, its integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners.
See all Align Technology regulatory filings.This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
